期刊文献+

非黑色素性皮肤癌组织中血管内皮生长因子及其受体1和受体2的表达 被引量:5

Expressions of VEGF,Flt-1 and KDR protein in skin SCC and BCC tissue
下载PDF
导出
摘要 目的:检测皮肤鳞状细胞癌(SCC)和基底细胞癌(BCC)组织中血管内皮生长因子(VEGF)及其受体1(Flt-1)、受体2(KDR)的表达。方法:应用免疫组化SP法检测26例皮肤SCC、18例BCC组织中VEGF、Flt-1和KDR的表达。取10例正常皮肤组织标本作对照。结果:皮肤SCC、BCC和正常皮肤组织中VEGF的表达水平分别为(129.05±9.93)、(119.40±9.37)及(85.25±12.98),Flt-1的表达水平分别为(130.48±12.02)、(116.90±13.45)及(82.19±9.15),KDR的表达水平分别为(136.60±6.67)、(120.95±6.33)和(85.43±9.33),3组间VEGF、Flt-1和KDR蛋白的表达差异均有统计学意义(F分别为83.418、78.137和169.125,P均<0.001)。皮肤SCC组织中VEGF与Flt-1(r=0.773,P<0.001)、VEGF与KDR(r=0.676,P<0.001)、Flt-1与KDR(r=0.718,P<0.001)的表达均呈正相关。结论:VEGF及其受体的过表达可能与非黑色素性皮肤癌的发生有关。 Aim:To detect the expressions of vascular endothelial growth factor(VEGF),VEGF receptor-1(Flt-1) and receptor-2(KDR) in cutaneous squamous cell carcinoma(SCC)and basal cell carcinoma(BCC) tissue.Methods:The expressions of VEGF,Flt-1 and KDR in 26 cases of SCC,18 cases of BCC and 10 normal skin tissue were examined using immunohistochemical SP methods.Results:In SCC,BCC and normal skin tissue,the expression level of VEGF was(129.05±9.93),(119.40±9.37) and(85.25±12.98);the level of Flt-1 was(130.48±12.02),(116.90±13.45) and(82.19±9.15);the level of KDR was(136.60±6.67),(120.95±6.33) and(85.43±9.33).There were significant differences in the expression levels of VEGF,Flt-1 and KDR among the three groups(F=83.418,78.137,and 169.125,P0.001).In SCC group,the expression levels of VEGF was positively related to those of Flt-1(r=0.773,P0.001)and KDR(r=0.676,P0.001),and that of Flt-1 was positively related to that of KDR(r=0.718,P0.001).Conclusion:The over expressions of VEGF,Flt-1 and KDR may play key roles in the development of cutaneous SCC and BCC.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2012年第2期215-218,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 皮肤肿瘤 鳞状细胞癌 基底细胞癌 血管内皮生长因子 血管内皮生长因子受体 cutaneous neoplasm squamous cell carcinoma basal cell carcinoma vascular endothelial growth factor vascular endothelial growth factor receptor
  • 相关文献

参考文献9

  • 1Stratton SP.Prevention of non-melanoma skin cancer[J].Curr Oncol Rep,2001,3(4):295.
  • 2Lacal PM,Ruffini F,Pagani E,et al.An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells[J].Int J Oncol,2005,27(6):1625.
  • 3Vieira JM,Santos SC,Espadinha C,et al.Expression of vascular endothelial growth factor(VEGF)and its recep-tors in thyroid carcinomas of follicular origin:a potential autocrine loop[J].Eur J Pathol,2005,153(5):701.
  • 4Wey JS,Fan F,Gray MJ,et al.Vascular endothelial growth factor receptor1promotes migration and invasion in pancre-atic carcinoma cell lines[J].Cancer,2005,104(2):427.
  • 5李涛,范妤,刘芳.免疫组织化学图像光密度分析的标准化方法[J].解剖学杂志,2008,31(5):727-728. 被引量:30
  • 6Stinga AC,Margaritescu O,Stinga AS,et al.VEGFR1and VEGFR2immunohistochemical expression in oral squa-mous cell carcinoma:a morphometric study[J].Rom J Morphol Embryol,2011,52(4):1269.
  • 7Bondo H.Vascular endothelial growth factor and bevacitum-ab in breast cancer[J].Breast Cancer,2007,14(2):163.
  • 8马骊,王小宁,张智清,周小明,曾革非,陈爱君.人血管内皮生长因子受体配体结合域[J].生物化学与生物物理学报,2000,32(5):463-468. 被引量:2
  • 9Roskoski R Jr.Vascular endothelial growth factor(VEGF)signaling in tumor progression[J].Crit Rev Oncol Hema-tol,2007,62(3):179.

二级参考文献7

  • 1Pan X,Acta Biochimicaet,1999年,3 1卷,4期,357页
  • 2Davis Smyth T,EMBO J,1996年,15卷,18期,4919页
  • 3Brey E M, Lalani Z, Johnston C, et al. Automated selection of DAB labeled tissue for immunohistochemical quantification [J]. J Histochem Cytochem, 2003,51 (5) : 575- 584.
  • 4Maximova O A, Taffs R E, Pomeroy K L, et al. Computerized morphometrie analysis of pathological prion protein deposition in scrapie-infected hamster brain [J]. J Histochem Cytoehem, 2006, 54(1):97-107.
  • 5Schmitt O, Preusse S, Haas S J. Comparison of contrast, sensitivity and efficiency of signal amplified and nonamplified immunohistochemical reactions suitable for videomicroscopy-based quantification and neuroimaging [J]. Brain Res Brain Res Protoc, 2004,12 (3): 157-171.
  • 6Docherty C C, Kalmar-Nagy J, Engelen M, et al. Effect of in vivo fetal infusion of dexamethasone at 0. 75 GA on fetal ovine resist ante artery responses to ET-1 [J]. Am J Physiol Regul Integr Comp Physiol, 2001,281(1):R261-268.
  • 7Hardie D C, Gregory T R, Hebert P D. From pixels to picograms a beginners' guide to genome quantification by Feulgen image anal ysis densitometry [J]. J Histochem Cytochem, 2002, 50 ( 6 ) 735-749.

共引文献30

同被引文献61

  • 1刘庆淮,谢平,戈应宾,袁孝如.糖尿病患者眼前房液血管内皮生长因子与转化生长因子β_2的变化[J].国际眼科杂志,2004,4(6):1015-1018. 被引量:9
  • 2王勇,王峰超,魏泓,倪勇,吴军,高翔.皮肤组织特异性表达hCTLA4-Ig转基因小鼠品系的建立[J].Acta Genetica Sinica,2005,32(9):916-922. 被引量:3
  • 3王伟莲,陈葵.10例颜面部皮肤恶性肿瘤切除术的围手术期护理体会[J].广东医学院学报,2007,25(2):237-238. 被引量:3
  • 4刘东宁,刘哲丽.增殖性糖尿病视网膜病变基质金属蛋白酶的表达[J].国际眼科杂志,2007,7(3):682-684. 被引量:6
  • 5Bakhle YS. COX-2 and cancer: a new approach to an old problem[J]. Br J Pharmacol,2001,134(6) : 1137-1150.
  • 6Palazon A,Martinez-Forero I,Teijeira A,et al. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD 137 (4-1B B ) for immunotherapy[J]. Cancer Discov, 2012,2 (7) : 608-623.
  • 7Javanmard SH,Hasanpour Z,Abbaspoor Z,et al.Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients.J Res Med Sci 2012; 17(12):1124-1127.
  • 8Ogata N,Nishikawa M,Nishimura T,et al.Unbalanced vitreous levels of pigment epithelium-derived factor and Vascularendothelial growth factor in diabetic retinopathy.Am J Ophthalmol 2002; 134: 348-353.
  • 9Sonoda S,Sakamoto T,Shirasawa M,et al.Correlation Between Reflectivity of Subretinal Fluid in OCT Images and Concentration of Intravitreal VEGF in Eyes With Diabetic Macular Edema.Invest Ophthalmol Vis Sci 2013; 54(8): 5367-5374.
  • 10Agrawal SS,Naqvi S,Gupta SK,et al.Prevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanisms.Food Chem Toxicol 2012; 50(9): 3126-3132.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部